Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 357

1.

Molecular profiling refines minimal residual disease-based prognostic assessment in adults with Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia.

Ribera J, Zamora L, Morgades M, Vives S, Granada I, Montesinos P, Gómez-Seguí I, Mercadal S, Guàrdia R, Nomdedeu J, Pratcorona M, Tormo M, Martínez-Lopez J, Hernández-Rivas JM, Ciudad J, Orfao A, González-Campos J, Barba P, Escoda L, Esteve J, Genescà E, Solé F, Feliu E, Ribera JM; Spanish PETHEMA Group; Spanish Society of Hematology.

Genes Chromosomes Cancer. 2019 Nov;58(11):815-819. doi: 10.1002/gcc.22788. Epub 2019 Aug 7.

PMID:
31340073
2.

Diagnostic and prognostic contribution of targeted NGS in patients with triple-negative myeloproliferative neoplasms.

Acha P, Xandri M, Fuster-Tormo F, Palomo L, Xicoy B, Cabezón M, Marcé S, Granada I, Vela D, Sagüés M, Boque C, Plensa E, Pineda A, Feliu E, Solé F, Zamora L.

Am J Hematol. 2019 Oct;94(10):E264-E267. doi: 10.1002/ajh.25580. Epub 2019 Aug 6. No abstract available.

PMID:
31321810
3.

The Multistationarity Structure of Networks with Intermediates and a Binomial Core Network.

Sadeghimanesh A, Feliu E.

Bull Math Biol. 2019 Jul;81(7):2428-2462. doi: 10.1007/s11538-019-00612-1. Epub 2019 May 17.

PMID:
31102135
4.

Incidence and outcome after first molecular versus overt recurrence in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia included in the ALL Ph08 trial from the Spanish PETHEMA Group.

Ribera JM, García O, Moreno MJ, Barba P, García-Cadenas I, Mercadal S, Montesinos P, Barrios M, González-Campos J, Martínez-Carballeira D, Gil C, Ribera J, Vives S, Novo A, Cervera M, Serrano J, Lavilla E, Abella E, Tormo M, Amigo ML, Artola MT, Genescà E, Bravo P, García-Belmonte D, García-Guiñón A, Hernández-Rivas JM, Feliu E; PETHEMA Group of the Spanish Society of Hematology.

Cancer. 2019 Aug 15;125(16):2810-2817. doi: 10.1002/cncr.32156. Epub 2019 Apr 23.

PMID:
31012967
5.

The poor prognosis of low hypodiploidy in adults with B-cell precursor acute lymphoblastic leukaemia is restricted to older adults and elderly patients.

Ribera J, Granada I, Morgades M, Vives S, Genescà E, González C, Nomdedeu J, Escoda L, Montesinos P, Mercadal S, Coll R, González-Campos J, Abella E, Barba P, Bermúdez A, Gil C, Tormo M, Pedreño M, Martínez-Carballeira D, Hernández-Rivas JM, Orfao A, Martínez-López J, Esteve J, Bravo P, Garcia-Guiñon A, Debén G, Moraleda JM, Queizán JA, Ortín X, Moreno MJ, Feliu E, Solé F, Ribera JM; PETHEMA Group, Spanish Society of Haematology.

Br J Haematol. 2019 Jul;186(2):263-268. doi: 10.1111/bjh.15887. Epub 2019 Mar 27.

PMID:
30916384
6.

Multistationarity and Bistability for Fewnomial Chemical Reaction Networks.

Feliu E, Helmer M.

Bull Math Biol. 2019 Apr;81(4):1089-1121. doi: 10.1007/s11538-018-00555-z. Epub 2018 Dec 18.

PMID:
30564990
7.

Increased survival due to lower toxicity for high-risk T-cell acute lymphoblastic leukemia patients in two consecutive pediatric-inspired PETHEMA trials.

Barba P, Morgades M, Montesinos P, Gil C, Fox ML, Ciudad J, Moreno MJ, González-Campos J, Genescà E, Martínez-Carballeira D, Martino R, Vives S, Guardia R, Mercadal S, Artola MT, Cladera A, Tormo M, Esteve J, Bergua J, Vall-Llovera F, Ribera J, Martínez-Sanchez P, Amigo ML, Bermúdez A, Calbacho M, Hernández-Rivas JM, Feliu E, Orfao A, Ribera JM.

Eur J Haematol. 2019 Jan;102(1):79-86. doi: 10.1111/ejh.13178. Epub 2018 Nov 22.

PMID:
30267597
8.

Frequency and clinical impact of CDKN2A/ARF/CDKN2B gene deletions as assessed by in-depth genetic analyses in adult T cell acute lymphoblastic leukemia.

Genescà E, Lazarenkov A, Morgades M, Berbis G, Ruíz-Xivillé N, Gómez-Marzo P, Ribera J, Juncà J, González-Pérez A, Mercadal S, Guardia R, Artola MT, Moreno MJ, Martínez-López J, Zamora L, Barba P, Gil C, Tormo M, Cladera A, Novo A, Pratcorona M, Nomdedeu J, González-Campos J, Almeida M, Cervera J, Montesinos P, Batlle M, Vives S, Esteve J, Feliu E, Solé F, Orfao A, Ribera JM.

J Hematol Oncol. 2018 Jul 24;11(1):96. doi: 10.1186/s13045-018-0639-8.

9.

Plasma Epstein-Barr Virus Load as an Early Biomarker and Prognostic Factor of Human Immunodeficiency Virus-related Lymphomas.

Muncunill J, Baptista MJ, Hernandez-Rodríguez Á, Dalmau J, Garcia O, Tapia G, Moreno M, Sancho JM, Martínez-Picado J, Feliu E, Mate JL, Ribera JM, Navarro JT.

Clin Infect Dis. 2019 Feb 15;68(5):834-843. doi: 10.1093/cid/ciy542.

PMID:
29982484
10.

Impact of mutational studies on the diagnosis and the outcome of high-risk myelodysplastic syndromes and secondary acute myeloid leukemia patients treated with 5-azacytidine.

Cabezón M, Bargay J, Xicoy B, García O, Borrás J, Tormo M, Marcé S, Pedro C, Valcárcel D, Jiménez MJ, Guàrdia R, Palomo L, Brunet S, Vall-Llovera F, Garcia A, Feliu E, Zamora L; CETLAM Group.

Oncotarget. 2018 Apr 10;9(27):19342-19355. doi: 10.18632/oncotarget.25046. eCollection 2018 Apr 10.

11.

Node balanced steady states: Unifying and generalizing complex and detailed balanced steady states.

Feliu E, Cappelletti D, Wiuf C.

Math Biosci. 2018 Jul;301:68-82. doi: 10.1016/j.mbs.2018.03.002. Epub 2018 Mar 28.

PMID:
29601834
12.

Comparison of intensive, pediatric-inspired therapy with non-intensive therapy in older adults aged 55-65 years with Philadelphia chromosome-negative acute lymphoblastic leukemia.

Ribera JM, García O, Gil C, Mercadal S, García-Cadenas I, Montesinos P, Barba P, Vives S, González-Campos J, Tormo M, Esteve J, López A, Moreno MJ, Ribera J, Alonso N, Bermúdez A, Amigo ML, Genescà E, García D, Vall-Llovera F, Bergua JM, Guàrdia R, Monteserín MC, Bernal T, Calbacho M, Martínez MP, Feliu E; PETHEMA Group.

Leuk Res. 2018 May;68:79-84. doi: 10.1016/j.leukres.2018.03.010. Epub 2018 Mar 19.

PMID:
29574396
13.

Consistency of the Moreau CLL score.

Sorigue M, Sarrate E, Franch-Sarto M, Feliu E, Junca J.

J Clin Lab Anal. 2018 Jun;32(5):e22376. doi: 10.1002/jcla.22376. Epub 2017 Dec 28.

PMID:
29282771
14.

Adoption of Bio/Data Collagen for the assessment of platelet function with the Multiplate® Analyzer.

Sorigue M, Morales-Indiano C, Ruiz-Garcia L, Peña M, Nieto J, Martínez-Iribarren A, Feliu E, Llopis MA, Orna E.

Thromb Res. 2018 Jan;161:33-35. doi: 10.1016/j.thromres.2017.11.008. Epub 2017 Nov 15. No abstract available.

PMID:
29178988
15.

Efficacy and safety of native versus pegylated Escherichia coli asparaginase for treatment of adults with high-risk, Philadelphia chromosome-negative acute lymphoblastic leukemia.

Ribera JM, Morgades M, Montesinos P, Martino R, Barba P, Soria B, Bermúdez A, Moreno MJ, González-Campos J, Vives S, Gil C, Abella E, Guàrdia R, Martínez-Carballeira D, Martínez-Sánchez P, Amigo ML, Mercadal S, Serrano A, López-Martínez A, Vall-Llovera F, Sánchez-Sánchez MJ, Peñarrubia MJ, Calbacho M, Méndez JA, Bergua J, Cladera A, Tormo M, García-Belmonte D, Feliu E, Ciudad J, Orfao A; PETHEMA Group, Spanish Society of Hematology.

Leuk Lymphoma. 2018 Jul;59(7):1634-1643. doi: 10.1080/10428194.2017.1397661. Epub 2017 Nov 22.

PMID:
29165013
16.

DNA methylation profile in chronic myelomonocytic leukemia associates with distinct clinical, biological and genetic features.

Palomo L, Malinverni R, Cabezón M, Xicoy B, Arnan M, Coll R, Pomares H, García O, Fuster-Tormo F, Grau J, Feliu E, Solé F, Buschbeck M, Zamora L.

Epigenetics. 2018;13(1):8-18. doi: 10.1080/15592294.2017.1405199. Epub 2018 Feb 6.

17.

Difference in CD5 and CD10 expression according to anatomic site.

Sorigue M, Triguero A, Feliu E, Junca J.

Int J Lab Hematol. 2018 Feb;40(1):e4-e7. doi: 10.1111/ijlh.12748. Epub 2017 Nov 6. No abstract available.

PMID:
29106047
18.

Identifying parameter regions for multistationarity.

Conradi C, Feliu E, Mincheva M, Wiuf C.

PLoS Comput Biol. 2017 Oct 3;13(10):e1005751. doi: 10.1371/journal.pcbi.1005751. eCollection 2017 Oct.

19.

Copy number profiling of adult relapsed B-cell precursor acute lymphoblastic leukemia reveals potential leukemia progression mechanisms.

Ribera J, Zamora L, Morgades M, Mallo M, Solanes N, Batlle M, Vives S, Granada I, Juncà J, Malinverni R, Genescà E, Guàrdia R, Mercadal S, Escoda L, Martinez-Lopez J, Tormo M, Esteve J, Pratcorona M, Martinez-Losada C, Solé F, Feliu E, Ribera JM; Spanish PETHEMA Group and the Spanish Society of Hematology.

Genes Chromosomes Cancer. 2017 Nov;56(11):810-820. doi: 10.1002/gcc.22486. Epub 2017 Aug 26.

PMID:
28758283
20.

Intermediates and Generic Convergence to Equilibria.

de Freitas MM, Wiuf C, Feliu E.

Bull Math Biol. 2017 Jul;79(7):1662-1686. doi: 10.1007/s11538-017-0303-4. Epub 2017 Jun 15.

PMID:
28620882
21.

HIV-infection has no prognostic impact on advanced-stage Hodgkin lymphoma.

Sorigué M, García O, Tapia G, Baptista MJ, Moreno M, Mate JL, Sancho JM, Feliu E, Ribera JM, Navarro JT.

AIDS. 2017 Jun 19;31(10):1445-1449. doi: 10.1097/QAD.0000000000001487.

PMID:
28574963
22.

Frequency and prognostic significance of additional cytogenetic abnormalities to the Philadelphia chromosome in young and older adults with acute lymphoblastic leukemia.

Motlló C, Ribera JM, Morgades M, Granada I, Montesinos P, Mercadal S, González-Campos J, Moreno MJ, Barba P, Cervera M, Barrios M, Novo A, Bernal T, Hernández-Rivas JM, Abella E, Amigo ML, Tormo M, Martino R, Lavilla E, Bergua J, Serrano A, García-Belmonte D, Guàrdia R, Grau J, Feliu E; PETHEMA Group, Spanish Society of Hematology.

Leuk Lymphoma. 2018 Jan;59(1):146-154. doi: 10.1080/10428194.2017.1326596. Epub 2017 May 30.

PMID:
28554259
23.

Incidence and prognostic significance of nephrotoxicity in patients receiving eshap as salvage therapy for lymphoma.

Sorigue M, Sancho JM, Pineda A, Garcia O, Lopez D, Moreno M, Tapia G, Batlle M, Ferra C, Vives S, Ibarra G, Feliu E, Ribera JM.

Leuk Res. 2017 Jul;58:98-101. doi: 10.1016/j.leukres.2017.05.001. Epub 2017 May 4.

PMID:
28521176
24.

Retinal vein occlusion and paroxysmal nocturnal hemoglobinuria.

Sorigue M, Juncà J, Orna E, Romanic N, Sarrate E, Castellvi J, Soler M, Rodríguez-Hernandez I, Feliu E, Ruiz S.

J Thromb Thrombolysis. 2017 Jul;44(1):63-66. doi: 10.1007/s11239-017-1502-4.

PMID:
28447244
25.

Usefulness of bronchoalveolar lavage and flow cytometry in patients with hematological malignancies and respiratory failure.

Ferrà C, Xicoy B, Castillo N, Morgades M, Juncà J, Andreo F, Millá F, Feliu E, Ribera JM.

Med Clin (Barc). 2017 Apr 7;148(7):297-302. doi: 10.1016/j.medcli.2016.10.045. Epub 2017 Jan 28. English, Spanish.

PMID:
28143650
26.

Similar prognosis of transformed and de novo diffuse large B-cell lymphomas in patients treated with immunochemotherapy.

Sorigue M, Garcia O, Baptista MJ, Sancho JM, Tapia G, Mate JL, Feliu E, Navarro JT, Ribera JM.

Med Clin (Barc). 2017 Mar 22;148(6):243-249. doi: 10.1016/j.medcli.2016.09.050. Epub 2016 Dec 27. English, Spanish.

PMID:
28038857
27.

Core signalling motif displaying multistability through multi-state enzymes.

Feng S, Sáez M, Wiuf C, Feliu E, Soyer OS.

J R Soc Interface. 2016 Oct;13(123). pii: 20160524.

28.

Large fracture of the anteromedial tibial plateau with isolated posterolateral knee corner injury: case series of an often missed unusual injury pattern.

Tomás-Hernández J, Monyart JM, Serra JT, Vinaixa MR, Farfan EG, García VM, Feliu EC.

Injury. 2016 Sep;47 Suppl 3:S35-S40. doi: 10.1016/S0020-1383(16)30604-0. Review.

PMID:
27692105
29.

Relapse risk after autologous stem cell transplantation in patients with lymphoma based on CD34+ cell dose.

Sorigue M, Sancho JM, Morgades M, Moreno M, Grífols JR, Alonso E, Juncà J, Ferrà C, Batlle M, Vives S, Motlló C, García-Caro M, Navarro JT, Millà F, Feliu E, Ribera JM.

Leuk Lymphoma. 2017 Apr;58(4):916-922. doi: 10.1080/10428194.2016.1222378. Epub 2016 Aug 26.

PMID:
27561733
30.

Targeted deep sequencing improves outcome stratification in chronic myelomonocytic leukemia with low risk cytogenetic features.

Palomo L, Garcia O, Arnan M, Xicoy B, Fuster F, Cabezón M, Coll R, Ademà V, Grau J, Jiménez MJ, Pomares H, Marcé S, Mallo M, Millá F, Alonso E, Sureda A, Gallardo D, Feliu E, Ribera JM, Solé F, Zamora L.

Oncotarget. 2016 Aug 30;7(35):57021-57035. doi: 10.18632/oncotarget.10937.

31.

Intermediates, catalysts, persistence, and boundary steady states.

Marcondes de Freitas M, Feliu E, Wiuf C.

J Math Biol. 2017 Mar;74(4):887-932. doi: 10.1007/s00285-016-1046-9. Epub 2016 Aug 1.

PMID:
27480320
32.

Graphical reduction of reaction networks by linear elimination of species.

Sáez M, Wiuf C, Feliu E.

J Math Biol. 2017 Jan;74(1-2):195-237. doi: 10.1007/s00285-016-1028-y. Epub 2016 May 24.

PMID:
27221101
33.

Epstein-Barr viral loads and serum free light chains levels are potential follow-up markers of HIV-related lymphomas.

Baptista MJ, Hernandez-Rodriguez A, Martinez-Caceres E, Morgades M, Martinez-Picado J, Sirera G, Sancho JM, Feliu E, Ribera JM, Navarro JT.

Leuk Lymphoma. 2017 Jan;58(1):211-213. Epub 2016 Apr 28. No abstract available.

PMID:
27124578
34.

Frequency and prognostic significance of t(v;11q23)/KMT2A rearrangements in adult patients with acute lymphoblastic leukemia treated with risk-adapted protocols.

Motlló C, Ribera JM, Morgades M, Granada I, Montesinos P, Brunet S, Bergua J, Tormo M, García-Boyero R, Sarrà J, Del Potro E, Grande C, Barba P, Bernal T, Amigo ML, Grau J, Cervera J, Feliu E; PETHEMA Group, Spanish Society of Hematology.

Leuk Lymphoma. 2017 Jan;58(1):145-152. Epub 2016 Apr 27.

PMID:
27122129
35.

Highly variable mutational profile of ASXL1 in myelofibrosis.

Sorigué M, Ribera JM, García O, Cabezón M, Vélez P, Marcé S, Xicoy B, Fernández C, Buch J, Cortes M, Plensa E, Gallardo D, Boqué C, Feliu E, Zamora L.

Eur J Haematol. 2016 Oct;97(4):331-5. doi: 10.1111/ejh.12731. Epub 2016 Jan 19.

PMID:
26714837
36.

National climate policies across Europe and their impacts on cities strategies.

Heidrich O, Reckien D, Olazabal M, Foley A, Salvia M, de Gregorio Hurtado S, Orru H, Flacke J, Geneletti D, Pietrapertosa F, Hamann JJ, Tiwary A, Feliu E, Dawson RJ.

J Environ Manage. 2016 Mar 1;168:36-45. doi: 10.1016/j.jenvman.2015.11.043. Epub 2015 Dec 13.

PMID:
26696604
37.

Feasibility and results of subtype-oriented protocols in older adults and fit elderly patients with acute lymphoblastic leukemia: Results of three prospective parallel trials from the PETHEMA group.

Ribera JM, García O, Oriol A, Gil C, Montesinos P, Bernal T, González-Campos J, Lavilla E, Ribera J, Brunet S, Martínez MP, Tormo M, Genescà E, Barba P, Sarrà J, Monteserín MC, Soria B, Colorado M, Cladera A, García-Guiñón A, Calbacho M, Serrano A, Ortín X, Pedreño M, Amigo ML, Escoda L, Feliu E; PETHEMA Group, Spanish Society of Hematology.

Leuk Res. 2016 Feb;41:12-20. doi: 10.1016/j.leukres.2015.11.012. Epub 2015 Dec 2.

PMID:
26686475
38.

Prognostic significance of copy number alterations in adolescent and adult patients with precursor B acute lymphoblastic leukemia enrolled in PETHEMA protocols.

Ribera J, Morgades M, Zamora L, Montesinos P, Gómez-Seguí I, Pratcorona M, Sarrà J, Guàrdia R, Nomdedeu J, Tormo M, Martínez-Lopez J, Hernández-Rivas JM, González-Campos J, Barba P, Escoda L, Genescà E, Solé F, Millá F, Feliu E, Ribera JM; Spanish PETHEMA Group and the Spanish Society of Hematology.

Cancer. 2015 Nov 1;121(21):3809-17. doi: 10.1002/cncr.29579. Epub 2015 Jul 20.

39.

The long term follow-up of early stage follicular lymphoma treated with radiotherapy, chemotherapy or combined modality treatment.

Sancho JM, García O, Mercadal S, Pomares H, Fernández-Alvarez R, González-Barca E, Tapia G, González-García E, Moreno M, Domingo-Domènech E, Sorigué M, Navarro JT, Motlló C, Fernández-de-Sevilla A, Feliu E, Ribera JM.

Leuk Res. 2015 Aug;39(8):853-8. doi: 10.1016/j.leukres.2015.05.009. Epub 2015 May 28.

PMID:
26122511
40.

Unlimited multistability and Boolean logic in microbial signalling.

Kothamachu VB, Feliu E, Cardelli L, Soyer OS.

J R Soc Interface. 2015 Jul 6;12(108):20150234. doi: 10.1098/rsif.2015.0234.

41.

Finding the positive feedback loops underlying multi-stationarity.

Feliu E, Wiuf C.

BMC Syst Biol. 2015 May 28;9:22. doi: 10.1186/s12918-015-0164-0.

42.

A thirty-five nucleotides BCR-ABL1 insertion mutation of controversial significance confers resistance to imatinib in a patient with chronic myeloid leukemia (CML).

Marcé S, Cortés M, Zamora L, Cabezón M, Grau J, Millá F, Feliu E.

Exp Mol Pathol. 2015 Aug;99(1):16-8. doi: 10.1016/j.yexmp.2015.04.007. Epub 2015 Apr 22.

PMID:
25913326
43.

Phosphorelay of non-orthodox two component systems functions through a bi-molecular mechanism in vivo: the case of ArcB.

Jovanovic G, Sheng X, Ale A, Feliu E, Harrington HA, Kirk P, Wiuf C, Buck M, Stumpf MP.

Mol Biosyst. 2015 May;11(5):1348-59. doi: 10.1039/c4mb00720d.

PMID:
25797699
44.

HIV-infection impact on clinical-biological features and outcome of diffuse large B-cell lymphoma treated with R-CHOP in the combination antiretroviral therapy era.

Baptista MJ, Garcia O, Morgades M, Gonzalez-Barca E, Miralles P, Lopez-Guillermo A, Abella E, Moreno M, Sancho JM, Feliu E, Ribera JM, Navarro JT.

AIDS. 2015 Apr 24;29(7):811-8. doi: 10.1097/QAD.0000000000000624.

PMID:
25730510
45.

Co-existence of JAK2 V617F and CALR mutations in primary myelofibrosis.

Zamora L, Xicoy B, Cabezón M, Fernandez C, Marcé S, Velez P, Xandri M, Gallardo D, Millá F, Feliu E, Boqué C.

Leuk Lymphoma. 2015;56(10):2973-4. doi: 10.3109/10428194.2015.1015124. Epub 2015 Mar 11. No abstract available.

PMID:
25686645
46.

Flow cytometry for detection of central nervous system disease in acute myeloid leukemia.

Sorigué M, Juncà J, Sancho JM, Morgades M, Esteban D, Navarro JT, Vives S, Feliu E, Ribera JM.

Leuk Lymphoma. 2015 Jul;56(7):2190-2. doi: 10.3109/10428194.2014.996752. Epub 2015 Mar 6. No abstract available.

PMID:
25641427
47.

Involvement of the -420C>G RETN polymorphism in myocardial fibrosis in patients with hypertrophic cardiomyopathy.

Hernández-Romero D, Orenes-Piñero E, García-Honrubia A, Climent V, Romero-Aniorte AI, Martínez CM, García-Bautista M, Martínez M, Feliu E, González J, Cánovas S, Montero-Argudo JA, Valdés M, Marín F.

J Intern Med. 2015 Jul;278(1):50-8. doi: 10.1111/joim.12334. Epub 2015 Jan 5.

48.

Calreticulin mutations are not present in patients with myeloproliferative chronic myelomonocytic leukemia.

Zamora L, Germing U, Cabezón M, Schuler E, Arnan M, Marcé S, Coll R, Pomares H, Brings C, Palomo L, Schmeneau J, Gallardo D, Millá F, Feliu E, Xicoy B.

Ann Hematol. 2015 May;94(5):869-71. doi: 10.1007/s00277-014-2262-2. Epub 2014 Nov 22. No abstract available.

PMID:
25413337
49.

Phosphate sink containing two-component signaling systems as tunable threshold devices.

Amin M, Kothamachu VB, Feliu E, Scharf BE, Porter SL, Soyer OS.

PLoS Comput Biol. 2014 Oct 30;10(10):e1003890. doi: 10.1371/journal.pcbi.1003890. eCollection 2014 Oct.

50.

Mitigating and adapting to climate change: multi-functional and multi-scale assessment of green urban infrastructure.

Demuzere M, Orru K, Heidrich O, Olazabal E, Geneletti D, Orru H, Bhave AG, Mittal N, Feliu E, Faehnle M.

J Environ Manage. 2014 Dec 15;146:107-115. doi: 10.1016/j.jenvman.2014.07.025. Epub 2014 Aug 24.

PMID:
25163601

Supplemental Content

Support Center